伯氏疏螺旋体血清阳性与老年人神经精神疾病及功能衰退风险的关联:衰老多学科研究
这项在法国西南农村开展的前瞻性6年队列研究纳入689名65岁以上退休农民,采用两步法检测伯氏疏螺旋体血清抗体,随访认知下降、痴呆、抑郁症状和功能衰退。血清阳性率为6.5%,粗分析和多因素调整后均未发现血清阳性与任何结局相关,痴呆风险比0.42(95%CI 0.1-1.17)。研究提示伯氏疏螺旋体血清阳性并非老年人神经精神疾病和功能衰退的危险因素。
要点
- 伯氏疏螺旋体血清阳性率6.5%,与认知下降、抑郁症状和功能衰退均无关联。
- 血清阳性者发生痴呆的风险比0.42(95%CI 0.1-1.17),未见风险增加。
- 结果需谨慎解读,因缺乏莱姆病临床表现、暴露时间和治疗信息。
核心结论
- 伯氏疏螺旋体血清阳性不是老年人神经精神疾病和功能衰退的危险因素。
研究设计与样本
- 前瞻性6年随访队列研究,纳入689名65岁及以上退休农民,来自法国西南农村,随机招募自农民健康保险系统。
- 伯氏疏螺旋体血清学采用两步法检测,随访期间反复评估认知下降、痴呆、抑郁症状和功能衰退。
主要发现
- 689名参与者中432名(62.2%)为男性,平均(SD)年龄75.8(6.4)岁,伯氏疏螺旋体血清阳性率为6.5%。
- 基线时血清阳性者较阴性者年龄更大、以男性为主、抑郁症状更轻。
- 粗分析和调整混杂因素后,血清阳性与认知下降、抑郁症状或功能衰退均无关联。
- 血清阳性者发生痴呆的风险比0.42(95%CI 0.1-1.17,调整多种混杂因素),未见风险增加。
关键数值与推荐
- 痴呆诊断采用三步程序;认知下降用简易精神状态检查评估;抑郁症状用流行病学研究中心抑郁量表评估。
- 功能障碍通过工具性日常生活活动能力和基本日常生活活动能力评分评估。
临床怎么用
- 对于伯氏疏螺旋体血清阳性的老年患者,不应仅凭血清阳性推断其神经精神症状或功能衰退与莱姆病相关。
- 在评估老年人认知下降、痴呆、抑郁或功能衰退时,伯氏疏螺旋体血清阳性不宜作为独立危险因素。
局限性
- 缺乏莱姆病临床表现、暴露日期或接受治疗的信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Exposure to Borrelia burgdorferi (Bb) has been reported to be associated with certain neuropsychiatric disorders. OBJECTIVE: To establish the association between seropositivity to Bb and incidental neuropsychiatric disorders (eg, cognitive decline, incident dementia, and depressive symptoms) as well as functional decline. DESIGN, SETTING, AND PARTICIPANTS: This prospective, 6-year follow-up cohort study was conducted in a rural southwestern region of France and included 689 retired farmers 65 years or older randomly recruited from the Farmer Health Insurance System who agreed to submit a blood sample and were participants in the Aging Multidisciplinary Investigation study, an ongoing epidemiological prospective study of aging initiated in 2007. The data were analyzed from April to May 2019. EXPOSURES: Borrelia burgdorferi serology testing was performed in a 2-tiered approach. During the follow-up period, cognitive decline, incident dementia, depressive symptoms, and functional decline were repeatedly assessed. MAIN OUTCOMES AND MEASURES: Diagnosis of dementia relied on a 3-step procedure; cognitive decline was determined using the Mini-Mental State Examination and depressive symptomatology was assessed using the Center for Epidemiologic Studies Depression scale. For disability, scores on instrumental and basic activities of daily living were investigated. RESULTS: Of 689 participants, 432 (62.2%) were men and the mean (SD) age was 75.8 (6.4) years. The seroprevalence rate of Bb was 6.5%. At baseline, compared with Bb- participants, those who were Bb+ were older, predominantly men, and had lower depressive symptoms. No association between seropositivity and any of the studied outcomes (ie, cognitive decline, depressive symptoms, or functional decline) was found in the crude analysis and after adjusting for confounding variables. Regarding incident dementia, no increased risk was found among Bb+ participants (hazard ratio, 0.42; 95% CI, 0.1-1.17; adjusted for diverse confounders). CONCLUSIONS AND RELEVANCE: To our knowledge, this is one of the few longitudinal studies exploring the risk of neuropsychiatric disorders and functional decline associated with exposure to Bb. Despite its limitations (eg, a lack of information if clinical manifestations of Lyme borreliosis existed, date of exposure, or treatment received), this study suggests that seropositivity to Bb is not a risk factor for incidental neuropsychiatric disorders and functional decline.
引用
- Ruiz VH, Edjolo A, Roubaud-Baudron C, et al. Association of Seropositivity to Borrelia burgdorferi With the Risk of Neuropsychiatric Disorders and Functional Decline in Older Adults: The Aging Multidisciplinary Investigation Study. JAMA Neurol. 2020. PMID: 31560067. doi:10.1001/jamaneurol.2019.3292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。